MarketInOut Stock Screener Log In | Sign Up
 

Biodesix Inc

NASDAQ • Healthcare • Diagnostics & Research • Quote as of 05/05/2026 16:00
Biodesix Inc stock price and volume chart

Company Profile

IndustryDiagnostics & Research
SectorHealthcare
ExchangeNASDAQ
Market Capitalization147.36 mln
Float5.21 mln
Earnings Date05/04/2026

Piotroski F-Score

4 / 9
Borderline

Beneish M-Score

-3.14
Reliable

Relative Strength

93 / 100
Top performer

Debt / Equity

-29.56
Negative equity

ROE

-610
Deeply negative

Dividend Yield

0.00%
No dividend

Business Description

Biodesix is a medical diagnostics company based in Louisville, Colorado, focused on helping doctors detect and manage lung cancer through blood-based testing. Its key products help identify whether lung nodules are likely to be cancerous and guide treatment decisions by analyzing tumor mutations and immune system activity. The company also supports pharmaceutical and life sciences firms with services ranging from early biomarker research through to clinical trial testing and regulatory assistance. Founded in 2005, Biodesix operates its own laboratories and has built its business around making lung cancer diagnosis faster and more precise.

Key Fundamentals

EPS-3.96
ROE-610
RPS11.65
ROIC-42.31
ROA-39.41
EBITDA, mln-21.95
EV / EBITDA-9.15
EV / EBIT-7.29
Revenue, mln88.50
EV / Revenue2.27

Financial Strength

Altman Z-Score-7.04
Piotroski F-Score 4 / 9
Beneish M-Score-3.14
Short Ratio2.55
Short % of Float3.08

Price Performance & Relative Strength

Period Price Performance Relative Strength
1 Week 50.15% 99 / 100   
1 Month -2.73% 17 / 100   
2 Months 34.84% 93 / 100   
6 Months 119% 98 / 100   
1 Year 44.21% 80 / 100   



Disclaimer - Privacy Policy - Terms Of Service - Cookie Use Policy - FAQ - Contact Us